VLC
Van Leeuwen & Company’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.82M | Sell |
52,025
-9,908
| -16% | -$537K | 1.43% | 23 |
|
|
2023
Q4 | $3.18M | Sell |
61,933
-18,087
| -23% | -$928K | 1.85% | 15 |
|
|
2023
Q3 | $4.64M | Buy |
80,020
+20
| +0% | +$1.16K | 2.89% | 11 |
|
|
2023
Q2 | $5.15M | Sell |
80,000
-2,575
| -3% | -$166K | 3.23% | 10 |
|
|
2023
Q1 | $5.72M | Sell |
82,575
-870
| -1% | -$60.3K | 3.84% | 6 |
|
|
2022
Q4 | $6M | Sell |
83,445
-577
| -0.7% | -$41.5K | 4.15% | 4 |
|
|
2022
Q3 | $5.97M | Sell |
84,022
-329
| -0.4% | -$23.4K | 4.76% | 6 |
|
|
2022
Q2 | $6.5M | Buy |
84,351
+81,136
| +2,524% | +$6.25M | 5.44% | 4 |
|
|
2022
Q1 | $235K | Sell |
3,215
-89,366
| -97% | -$6.53M | 0.17% | 61 |
|
|
2021
Q4 | $5.77M | Sell |
92,581
-2,225
| -2% | -$139K | 3.24% | 9 |
|
|
2021
Q3 | $5.61M | Buy |
94,806
+90
| +0.1% | +$5.33K | 3.44% | 8 |
|
|
2021
Q2 | $6.3M | Buy |
94,716
+44,838
| +90% | +$2.98M | 3.73% | 7 |
|
|
2021
Q1 | $3.15M | Buy |
49,878
+10,331
| +26% | +$652K | 2.07% | 18 |
|
|
2020
Q4 | $2.45M | Sell |
39,547
-51,510
| -57% | -$3.18M | 1.64% | 24 |
|
|
2020
Q3 | $5.49M | Buy |
91,057
+51,823
| +132% | +$3.12M | 4.27% | 4 |
|
|
2020
Q2 | $2.31M | Buy |
39,234
+2,822
| +8% | +$166K | 1.79% | 23 |
|
|
2020
Q1 | $2.03M | Buy |
36,412
+264
| +0.7% | +$14.7K | 1.95% | 19 |
|
|
2019
Q4 | $2.32M | Buy |
36,148
+16,781
| +87% | +$1.08M | 1.93% | 18 |
|
|
2019
Q3 | $982K | Sell |
19,367
-33,477
| -63% | -$1.7M | 0.93% | 43 |
|
|
2019
Q2 | $2.4M | Buy |
+52,844
| New | +$2.4M | 2.15% | 13 |
|